Financials

News Discussions Technicals Forecast Seasonals

EBITDA of Rapport Therapeutics, Inc.

Annual data

2023

2024

TTM

‪‪−84.00 M‬‬

‪‪−63.00 M‬‬

‪‪−42.00 M‬‬

‪‪−21.00 M‬‬

‪0.00‬

Period

Value

Change

Change %

TTM

‪‪−82.22 M‬‬

‪0.00‬

‪0.00‬%

2024

‪‪−82.22 M‬‬

‪‪−46.15 M‬‬

‪−127.95‬%

2023

‪‪−36.07 M‬‬

‪‪−25.71 M‬‬

‪−248.41‬%

Quarterly data

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

‪‪−24.00 M‬‬

‪‪−18.00 M‬‬

‪‪−12.00 M‬‬

‪‪−6.00 M‬‬

‪0.00‬

Period

Value

Change

Change %

Q4 '24

‪‪−23.26 M‬‬

‪‪−1.84 M‬‬

‪−8.59‬%

Q3 '24

‪‪−21.42 M‬‬

‪‪−829.00 K‬‬

‪−4.03‬%

Q2 '24

‪‪−20.59 M‬‬

‪‪−3.65 M‬‬

‪−21.54‬%

Q1 '24

‪‪−16.94 M‬‬

‪‪−10.33 M‬‬

‪−156.35‬%

Q2 '23

‪‪−6.61 M‬‬

‪‪−1.43 M‬‬

‪−27.69‬%